Macrophages polarize in response to environmental cues to assume specific phenotypes important for tissue homeostasis, host defense, and adaptation to injury and stress. Macrophage polarization also occurs in chronic inflammatory disorders and tumors and is an important driver of disease pathology. The long term goals of this project are to understand how macrophage polarization is regulated and how the polarized state affects macrophage responses to their environment to impact innate immunity and inflammatory responses. An associated goal is to use this knowledge to therapeutically modulate macrophage polarization to optimize host defense while minimizing inflammation-associated pathology. Recently, the importance of epigenetic mechanisms and cellular metabolism in macrophage polarization are increasingly appreciated. Epigenetics and metabolism share the ability to shape macrophage responses to their environment, are important emerging areas in macrophage research, and are linked mechanistically as epigenetic regulators utilize products of metabolic enzymes. IFN-?, often in combination with microbial products such as TLR ligands, polarizes macrophages towards an `M1' classical activation phenotype that is characterized by increased expression of chemokines, cytokines and antigen-presenting molecules, and enhanced microbial killing. Based on our overarching hypothesis that polarization-associated cell states are important determinants of macrophage function during immune and inflammatory responses, in the previous project period we investigated chromatin-based epigenetic mechanisms and changes in metabolism induced by IFN-? during M1 polarization of human macrophages, and how this affects inflammatory TLR-induced responses. We found that IFN-? globally reprograms the epigenetic landscape of macrophages by inducing stable STAT1 binding and changes in histone marks. IFN-?-induced chromatin remodeling cooperated with TLR signaling to synergistically activate inflammatory genes. We found a new link between epigenetics and metabolism, as IFN-? epigenetically silenced components of M2 alternative activation that included the master metabolic regulator PPAR?. IFN-? also altered macrophage metabolism by targeting mTORC1, which senses and coordinates cellular responses to the nutrient status of extracellular and intracellular microenvironments. Suppression of mTORC1 was associated with selective regulation of protein translation, autophagy, and skewing of inflammatory cytokine production. In this project, we will investigate mechanisms and functional consequences of epigenetic and metabolic regulation of human macrophage polarization by IFN-?, and how this alters macrophages to increase inflammatory activation and anti-microbial functions. We anticipate our studies will yield insights that can be used to develop therapies to modulate macrophage function in innate immune responses and inflammatory diseases.

Public Health Relevance

Macrophages engulf and destroy microbes and produce cytokines that are important for fighting infections and inflammation. The long term goals of this project are to understand how polarization of macrophages in response to environmental cues affects their immune and inflammatory functions, and to use this knowledge to develop new therapies. This project will focus on how the environment influences macrophage gene expression and cell metabolism to gain knowledge that can be used to suppress inflammation-associated damage to patients' tissues while potentially boosting beneficial macrophage functions in fighting infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI044938-18
Application #
9264460
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Peyman, John A
Project Start
2000-03-01
Project End
2020-04-30
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
18
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Hospital for Special Surgery
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10021
Manni, Michela; Gupta, Sanjay; Ricker, Edd et al. (2018) Regulation of age-associated B cells by IRF5 in systemic autoimmunity. Nat Immunol 19:407-419
Binder, Nikolaus; Miller, Christine; Yoshida, Masaki et al. (2017) Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption. J Immunol 198:3436-3447
Loupasakis, Konstantinos; Kuo, David; Sokhi, Upneet K et al. (2017) Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes. PLoS One 12:e0179762
Park, Sung Ho; Kang, Kyuho; Giannopoulou, Eugenia et al. (2017) Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation. Nat Immunol 18:1104-1116
Murata, Koichi; Fang, Celestia; Terao, Chikashi et al. (2017) Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis. Immunity 47:66-79.e5
Kang, Kyuho; Park, Sung Ho; Chen, Janice et al. (2017) Interferon-? Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF. Immunity 47:235-250.e4
Fang, Celestia; Qiao, Yu; Mun, Se Hwan et al. (2016) Cutting Edge: EZH2 Promotes Osteoclastogenesis by Epigenetic Silencing of the Negative Regulator IRF8. J Immunol 196:4452-4456
Foldi, Julia; Shang, Yingli; Zhao, Baohong et al. (2016) RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genes. Protein Cell 7:201-9
Miller, Christine H; Smith, Sinead M; Elguindy, Mahmoud et al. (2016) RBP-J-Regulated miR-182 Promotes TNF-?-Induced Osteoclastogenesis. J Immunol 196:4977-86
Huynh, Linda; Kusnadi, Anthony; Park, Sung Ho et al. (2016) Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci Rep 6:31959

Showing the most recent 10 out of 46 publications